S
AMPH icon

ShariaPortfolio’s Amphastar Pharmaceuticals AMPH Stock Holding History

ShariaPortfolio’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,019
Closed -$703K – 34
2024
Q1 		$703K Buy
16,019
+2,445
+18% +$126K 0.41% 27
2023
Q4 		$840K Buy
13,574
+1,069
+9% +$56.2K 0.57% 26
2023
Q3 		$575K Buy
+12,505
New +$682K 0.46% 31

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ShariaPortfolio's AMPH Position: Q2 2024 in Review

ShariaPortfolio sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2024, closing a stake of 16,019 shares — an estimated $703K sold.

ShariaPortfolio first reported a position in AMPH in Q3 2023 and held it in 3 quarters. The position peaked at $840K in Q4 2023. 268 funds tracked by Wall St. Rank hold AMPH as of Q2 2024.

  • ShariaPortfolio reported no remaining Amphastar Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • ShariaPortfolio sold 16,019 Amphastar Pharmaceuticals shares in Q2 2024, an estimated $703K.
  • ShariaPortfolio first reported a position in Amphastar Pharmaceuticals in Q3 2023 and held it in 3 quarters.
  • ShariaPortfolio's Amphastar Pharmaceuticals position peaked at $840K in Q4 2023.
  • 268 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2024.

Based on ShariaPortfolio's 13F filing for Q2 2024, filed 12 Aug 2024.